113 related articles for article (PubMed ID: 35487417)
41. MiRNA-93 functions as an oncogene in glioma by directly targeting RBL2.
Liu DK; Wei YJ; Guo Y; Wang J; Wang GH
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2343-2350. PubMed ID: 29762838
[TBL] [Abstract][Full Text] [Related]
42. Spectrum of RB1 gene mutations and loss of heterozygosity in Mexican patients with retinoblastoma: identification of six novel mutations.
Macías M; Dean M; Atkinson A; Jiménez-Morales S; García-Vazquez FJ; Saldaña-Alvarez Y; Ramírez-Bello J; Chávez M; Orozco L
Cancer Biomark; 2008; 4(2):93-9. PubMed ID: 18503160
[TBL] [Abstract][Full Text] [Related]
43. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway.
Lu F; Stedman W; Yousef M; Renne R; Lieberman PM
J Virol; 2010 Mar; 84(6):2697-706. PubMed ID: 20071580
[TBL] [Abstract][Full Text] [Related]
44. TGF-beta induced RBL2 expression in renal cancer cells by down-regulating miR-93.
Shi J; Zhuang Y; Liu XK; Zhang YX; Zhang Y
Clin Transl Oncol; 2014 Nov; 16(11):986-92. PubMed ID: 25183046
[TBL] [Abstract][Full Text] [Related]
45. Expression of the retinoblastoma family of tumor suppressors during murine embryonic orofacial development.
Leezer JL; Hackmiller RC; Greene RM; Pisano MM
Orthod Craniofac Res; 2003 Feb; 6(1):32-47. PubMed ID: 12627794
[TBL] [Abstract][Full Text] [Related]
46. "Monoallelic germline methylation and sequence variant in the promoter of the RB1 gene: a possible constitutive epimutation in hereditary retinoblastoma".
Quiñonez-Silva G; Dávalos-Salas M; Recillas-Targa F; Ostrosky-Wegman P; Aranda DA; Benítez-Bribiesca L
Clin Epigenetics; 2016; 8():1. PubMed ID: 26753011
[TBL] [Abstract][Full Text] [Related]
47. Mutational analysis of the RB1 gene in Moroccan patients with retinoblastoma.
Abidi O; Knari S; Sefri H; Charif M; Senechal A; Hamel C; Rouba H; Zaghloul K; El Kettani A; Lenaers G; Barakat A
Mol Vis; 2011; 17():3541-7. PubMed ID: 22219649
[TBL] [Abstract][Full Text] [Related]
48. Silencing of RB1 and RB2/P130 during adipogenesis of bone marrow stromal cells results in dysregulated differentiation.
Capasso S; Alessio N; Di Bernardo G; Cipollaro M; Melone MA; Peluso G; Giordano A; Galderisi U
Cell Cycle; 2014; 13(3):482-90. PubMed ID: 24281253
[TBL] [Abstract][Full Text] [Related]
49. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells.
Wang L; Pal S; Sif S
Mol Cell Biol; 2008 Oct; 28(20):6262-77. PubMed ID: 18694959
[TBL] [Abstract][Full Text] [Related]
50. Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
Dimaras H; Rushlow D; Halliday W; Doyle JJ; Babyn P; Abella EM; Williams J; Héon E; Gallie BL; Chan HS
Transl Res; 2010 Aug; 156(2):91-7. PubMed ID: 20627193
[TBL] [Abstract][Full Text] [Related]
51.
Price EA; Patel R; Scheimberg I; Kotiloglu Karaa E; Sagoo MS; Reddy MA; Onadim Z
Ophthalmic Genet; 2021 Oct; 42(5):604-611. PubMed ID: 34003079
[No Abstract] [Full Text] [Related]
52. Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins.
Vilas JM; Ferreirós A; Carneiro C; Morey L; Da Silva-Álvarez S; Fernandes T; Abad M; Di Croce L; García-Caballero T; Serrano M; Rivas C; Vidal A; Collado M
Oncotarget; 2015 Feb; 6(5):2992-3002. PubMed ID: 25576924
[TBL] [Abstract][Full Text] [Related]
53. Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation.
Bellan C; De Falco G; Tosi GM; Lazzi S; Ferrari F; Morbini G; Bartolomei S; Toti P; Mangiavacchi P; Cevenini G; Trimarchi C; Cinti C; Giordano A; Leoncini L; Tosi P; Cottier H
Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3602-8. PubMed ID: 12454024
[TBL] [Abstract][Full Text] [Related]
54. Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome.
Mehyar M; Mosallam M; Tbakhi A; Saab A; Sultan I; Deebajah R; Jaradat I; AlJabari R; Mohammad M; AlNawaiseh I; Al-Hussaini M; Yousef YA
Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):152-159. PubMed ID: 32222358
[TBL] [Abstract][Full Text] [Related]
55. Tumor suppressor pRb2/p130 gene and its derived product Spa310 spacer domain as perspective candidates for cancer therapy.
Giordano A; Rossi A; Romano G; Bagella L
J Cell Physiol; 2007 Nov; 213(2):403-6. PubMed ID: 17708530
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.
Liu F; Gong J; Huang W; Wang Z; Wang M; Yang J; Wu C; Wu Z; Han B
Oncogene; 2014 Oct; 33(40):4813-22. PubMed ID: 24166509
[TBL] [Abstract][Full Text] [Related]
57. Rapid identification of germline mutations in retinoblastoma by protein truncation testing.
Tsai T; Fulton L; Smith BJ; Mueller RL; Gonzalez GA; Uusitalo MS; O'Brien JM
Arch Ophthalmol; 2004 Feb; 122(2):239-48. PubMed ID: 14769601
[TBL] [Abstract][Full Text] [Related]
58. Orbital nodular fasciitis simulating a dermoid cyst in an 8-month-old child. Case report and review of the literature.
Shields JA; Shields CL; Christian C; Eagle RC
Ophthalmic Plast Reconstr Surg; 2001 Mar; 17(2):144-8. PubMed ID: 11281591
[TBL] [Abstract][Full Text] [Related]
59. Constitutional retinoblastoma gene deletion in Egyptian patients.
Mohammed AM; Kamel AK; Hammad SA; Afifi HH; El Sanabary Z; El Din ME
World J Pediatr; 2009 Aug; 5(3):222-5. PubMed ID: 19693468
[TBL] [Abstract][Full Text] [Related]
60. Constitutional genomic instability, chromosome aberrations in tumor cells and retinoblastoma.
Amare Kadam PS; Ghule P; Jose J; Bamne M; Kurkure P; Banavali S; Sarin R; Advani S
Cancer Genet Cytogenet; 2004 Apr; 150(1):33-43. PubMed ID: 15041221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
